Live feed16:15:00·597dPRReleasevia QuantisnowSolid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's AtaxiaByQuantisnow·Wall Street's wire, on your screen.SLDB· Solid Biosciences Inc.Health Care
